Clinical Trial Update: Lumasiran in Hyperoxalaemic Patients on Haemodialysis [Phase 2]

View source ↗

Summary

This update reports a Phase 2 clinical trial evaluating lumasiran for hyperoxalemia in patients on haemodialysis, and the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease
• Hyperoxalemia

Drugs mentioned

• Lumasiran (lumasiran)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Haemodialysis, Chronic Kidney Disease Requiring Chronic Dialysis | Phase 2 | Status: RECRUITING